课题基金 / 基金详情

Clinical significance of oncogenic mutations of p53 gene in oral cancen : Relationship of the mutations with radiation- and chemo-sensitivity

Clinical significance of oncogenic mutations of p53 gene in oral cancen : Relationship of the mutations with radiation- and chemo-sensitivity
口腔癌中p53基因致癌突变的临床意义:突变与放射和化疗敏感性的关系
批准号:
15592131
负责人:
KAWAMATA Hitoshi
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

KAWAMATA Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了来自人头颈部癌细胞系的几个突变型p53的功能多样性。将p5 3基因全长开放阅读框亚克隆到哺乳动物表达载体中,并测定其基因突变。然后,在缺乏p53基因的人骨肉瘤细胞系Saos-2细胞中检测它们的细胞内定位、转录活性和致癌功能。突变型P53(Glu17Lys,His193Leu)或截短型P53(Delta 121)不能激活含有p21waf1、bax、mdm2、p53AIP和PUMA基因应答元件的报告基因。然而,突变型p53(Asn30Ser)在所有的记者身上都显示出转录活性。另一方面,突变型p53(Asp28lHis)对p21waf1启动子有较强的激活作用,对MDM2启动子有微弱的激活作用,但对Bax启动子没有激活作用。有趣的是,这种突变型p53阻止了用DNA损伤剂阿霉素处理后的Saos-2细胞发生凋亡。突变型P53强烈诱导细胞周期停滞,但微弱地诱导细胞凋亡。另一个突变体P53(Glu17Lys,His193Leu)也可能以一种转录不依赖的方式阻止DNA损伤后的细胞凋亡。这些结果表明,某些头颈部癌细胞系存在P53基因的致癌突变,致癌的P53蛋白阻止了DNA损伤后的癌细胞发生凋亡。
英文摘要
We examined the functional diversity of several mutant-p53 derived from human head and neck cancer cell lines. Entire open reading frame of p53 cDNA was subcloned into a mammalian expression vector, and genetic mutations were determined. Then, their intracellular localization, transcriptional activity, and oncogenic function were examined in a human osteosarcoma cell line lacking p53 gene, Saos-2 cells. A mutant-p53 (Glu17Lys,His193Leu) or a truncated-p53 (delta 121) did not activate the reporters containing p53 responsive elements from p21waf1,BAX,MDM2,p53AIP, and PUMA genes. However, a mutant-p53 (Asn30Ser) showed the transcriptional activity on all of the reporters. On the other hand, a mutant-p53 (Asp28lHis) activated the p21waf1 promoter strongly and the MDM2 promoter faintly, but did not activate the BAX promoter. Interestingly, this mutant-p53 prevented Saos-2 cells from undergoing apoptosis after treatment with a DNA damaging agent, adriamycin. This mutant-p53 strongly induced cell cycle arrest but marginally induced apoptosis. Another mutant-p53 (Glu17Lys,His193Leu) also prevented the cells from undergoing apoptosis after DNA damage probably in a transcription-independent manner. These results suggest that some head and neck cancer cell lines contain the oncogenic mutation of p53 gene, and the oncogenic p53 protein prevents cancer cells from undergoing apoptosis after DNA damage.
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
Frequent Down-regulation of 14-3-3 σ protein and Hypermethylation of 14-3-3 σ gene in Salivary Gland Adenoid Cystic Carcinoma.
唾液腺腺样囊性癌中 14-3-3 σ 蛋白频繁下调和 14-3-3 σ 基因高甲基化。
DOI: --
发表时间: 2004
期刊: British Journal of Cancer. 91(6)
影响因子: --
作者: [Uchida D, Begum N-M, Almofti A, Yoshida H, Sato M.]
通讯作者: Sato M.
Kawamata H., Furihata T., Omotehara F., et al.: "Identification of genes differentially expressed in a newly isolated human metastasizing esophageal cancer cell line, T.Tn-AT1,by CDNA microarray."Cancer Sci.. 94・8. 699-706 (2003)
Kawamata H.、Furihata T.、Omotehara F. 等人:“通过 CDNA 微阵列鉴定新分离的人类转移性食管癌细胞系 T.Tn-AT1 中差异表达的基因。”Cancer Sci.. 94。 8. 699-706 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Horiuchi H, Kawamata H, Omotehara F, et al.: "Negative Immunohistochemical staining of p53 protein does not always reflect wild type p53 gene in cancer cells."J Gastroenterol. 印刷中.
Horiuchi H、Kawamata H、Omotehara F 等人:“p53 蛋白的阴性免疫组织化学染色并不总是反映癌细胞中的野生型 p53 基因。”J Gastroenterol 出版。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oncogenic mutation of p53 gene derived from head and neck cancer cell lines prevents cells from undergoing apoptosis after DNA damage
来自头颈癌细胞系的 p53 基因的致癌突变可防止细胞在 DNA 损伤后发生凋亡
DOI: --
发表时间: 2004
期刊: Br J Cancer (in press)
影响因子: --
作者: [Kawamata H, Omotehara F, Nakashiro K, Uchida D, Shinagawa Y, Tachibana M, Imai Y, Fujimori T.]
通讯作者: Fujimori T.
22
    Mechanism for acquiring the oncogenic function in mutated p53
    • 批准号:
      17592103
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2005
    • 负责人:
      KAWAMATA Hitoshi
    • 依托单位:
    Molecular diagnosis for occult oral cancer
    • 批准号:
      10671887
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      1998
    • 负责人:
      KAWAMATA Hitoshi
    • 依托单位:
    Role of the matrix-degrading enzymes and their inhibitors on invasion and metastasis of oral SCC
    • 批准号:
      08672315
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1996
    • 负责人:
      KAWAMATA Hitoshi
    • 依托单位:
    国内基金
    海外基金
    Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
    基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
    • 批准号:
      2026JJ82384
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      颜志鹏
    • 依托单位:
    白藜芦醇通过SIRT1/p53乙酰化调控铁死亡及其在口腔鳞状细胞癌顺铂增敏中的作用研究
    • 批准号:
      2026JJ80394
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      毛琛
    • 依托单位: